Natalie Harper, MD
Medical Oncology · Lexington, KYNPI 1730447814
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.8% of the total across 323 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 8.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,106 and has fallen 85.7% since, to $300 in 2025.
Across 323 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$483
- Johnson & Johnson$464
- Merck$451
- Amgen$374
- Seagen Inc.$338
- AstraZeneca$318
- plus $4K from 46 others
What the payments were for
- Food & beverage$5,43991%
- Education$5549%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,993 in reported general payments places this provider in the 55th percentile of 53 medical oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $2,546 |
| Anastrozole | 14 | $209 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Lexington
- Lowell AnthonyLexington$55K
- Zhonglin HaoLexington$15K
- Arvinda PadmanabhanLexington$13K
- Shawn PetersonLexington$11K
- Peng WangLexington$8K
- Zin MyintLexington$7K
- Reema PatelLexington$5K
- Ralph ZinnerLexington$5K
- Janeesh Sekkath-VeeduLexington$1K
- Mohamed AlsharediLexington$594
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.